This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2014 Jul;312(2):187-8.

doi: 10.1001/jama.2014.2198.

Quadrivalent human papillomavirus vaccine and the risk of venous thromboembolism

Nikolai Madrid Scheller¹, Björn Pasternak¹, Henrik Svanström¹, Anders Hviid¹

Affiliations

PMID: 25005658
DOI: 10.1001/jama.2014.2198

Quadrivalent human papillomavirus vaccine and the risk of venous thromboembolism

Nikolai Madrid Scheller et al. JAMA. 2014 Jul.

. 2014 Jul;312(2):187-8.

doi: 10.1001/jama.2014.2198.

Authors

Nikolai Madrid Scheller¹, Björn Pasternak¹, Henrik Svanström¹, Anders Hviid¹

Affiliation

¹ Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.

PMID: 25005658
DOI: 10.1001/jama.2014.2198

No abstract available

PubMed Disclaimer

Similar articles

Quadrivalent human papillomavirus vaccination in boys and risk of autoimmune diseases, neurological diseases and venous thromboembolism.
Frisch M, Besson A, Clemmensen KKB, Valentiner-Branth P, Mølbak K, Hviid A. Frisch M, et al. Int J Epidemiol. 2018 Apr 1;47(2):634-641. doi: 10.1093/ije/dyx273. Int J Epidemiol. 2018. PMID: 29425361
Safety of the quadrivalent human papillomavirus vaccine.
Brotherton JM. Brotherton JM. BMJ. 2013 Oct 9;347:f5631. doi: 10.1136/bmj.f5631. BMJ. 2013. PMID: 24108153 No abstract available.
Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study.
Arnheim-Dahlström L, Pasternak B, Svanström H, Sparén P, Hviid A. Arnheim-Dahlström L, et al. BMJ. 2013 Oct 9;347:f5906. doi: 10.1136/bmj.f5906. BMJ. 2013. PMID: 24108159 Free PMC article.
Human papillomavirus and the HPV vaccine: are the benefits worth the risks?
Knudtson M, Tiso S, Phillips S. Knudtson M, et al. Nurs Clin North Am. 2009 Sep;44(3):293-9. doi: 10.1016/j.cnur.2009.06.005. Nurs Clin North Am. 2009. PMID: 19683091 Review.
Quadrivalent human papillomavirus vaccine: updated recommendations for males.
Heesch CB, Hayney MS. Heesch CB, et al. J Am Pharm Assoc (2003). 2012 Mar-Apr;52(2):289-90. doi: 10.1331/JAPhA.2012.12511. J Am Pharm Assoc (2003). 2012. PMID: 22370386 Review. No abstract available.

See all similar articles

Cited by

Map of thrombogenesis in viral infections and viral-driven tumours.
Neto BV, Tavares V, Santos JMO, Cerqueira F, Pereira D, Medeiros R. Neto BV, et al. Discov Oncol. 2023 Jan 8;14(1):3. doi: 10.1007/s12672-022-00610-1. Discov Oncol. 2023. PMID: 36617364 Free PMC article. Review.
Maternal HPV Infection: Effects on Pregnancy Outcome.
Condrat CE, Filip L, Gherghe M, Cretoiu D, Suciu N. Condrat CE, et al. Viruses. 2021 Dec 7;13(12):2455. doi: 10.3390/v13122455. Viruses. 2021. PMID: 34960724 Free PMC article. Review.
Thrombosis and thrombocytopenia after HPV vaccination.
Johansen S, Laegreid IJ, Ernstsen SL, Azrakhsh NA, Kittang AO, Lindås R, Gjertsen BT, Vetti N, Mørtberg TV, Sørvoll IH, Holme PA, Ahlen MT, Reikvam H. Johansen S, et al. J Thromb Haemost. 2022 Mar;20(3):700-704. doi: 10.1111/jth.15604. Epub 2021 Dec 7. J Thromb Haemost. 2022. PMID: 34817130 Free PMC article.
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
Arbyn M, Xu L, Simoens C, Martin-Hirsch PP. Arbyn M, et al. Cochrane Database Syst Rev. 2018 May 9;5(5):CD009069. doi: 10.1002/14651858.CD009069.pub3. Cochrane Database Syst Rev. 2018. PMID: 29740819 Free PMC article. Review.
Safety of Human Papillomavirus Vaccines: An Updated Review.
Phillips A, Patel C, Pillsbury A, Brotherton J, Macartney K. Phillips A, et al. Drug Saf. 2018 Apr;41(4):329-346. doi: 10.1007/s40264-017-0625-z. Drug Saf. 2018. PMID: 29280070 Review.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information